Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Synerx Pharma, LLC
ClinicalTrials.gov Identifier:
NCT01467687
First received: October 31, 2011
Last updated: November 8, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)